Search research articles
Contact Us
Filters
Showing results (181-190 of 198) with videos related to
Page
of 20
Sort By:
Journal of Medicinal Chemistry
|
February 2, 2024
Identification of Novel, Selective Ataxia-Telangiectasia Mutated Kinase Inhibitors with the Ability to Penetrate the Blood-Brain Barrier: The Discovery of AZD1390
Kurt G Pike, Thomas A Hunt, Bernard Barlaam, et al.
Brain : a Journal of Neurology
|
June 18, 2010
Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency)
Philippa B Mills, Emma J Footitt, Kevin A Mills, et al.
Neurosurgery
|
March 8, 2024
40 Gray in 5 Fractions for Salvage Reirradiation of Spine Lesions Previously Treated With Stereotactic Body Radiotherapy
Assaf Moore, Zhigang Zhang, Teng Fei, et al.
Medchemcomm
|
October 18, 2016
Discovery of 4,6-disubstituted pyrimidines as potent inhibitors of the heat shock factor 1 (HSF1) stress pathway and CDK9
Carl S Rye, Nicola E A Chessum, Scott Lamont, et al.
Nature
|
August 10, 2017
An early modern human presence in Sumatra 73,000-63,000 years ago
K E Westaway, J Louys, R Due Awe, et al.
Nature Neuroscience
|
February 5, 2026
A generalizable foundation model for analysis of human brain MRI
Divyanshu Tak, Biniam A Garomsa, Anna Zapaishchykova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 24, 2024
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From <i>EGFR</i> and <i>ALK</i> Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC)
Luke R G Pike, Emily Miao, Lillian A Boe, et al.
Journal of Medicinal Chemistry
|
April 24, 2018
The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2 H-pyran-4-yl)-1,3-dihydro-2 H-imidazo[4,5- c]quinolin-2-one)
Kurt G Pike, Bernard Barlaam, Elaine Cadogan, et al.
Journal of Medicinal Chemistry
|
October 14, 2021
Discovery of a Series of 7-Azaindoles as Potent and Highly Selective CDK9 Inhibitors for Transient Target Engagement
Bernard Barlaam, Chris De Savi, Allan Dishington, et al.
ACS Medicinal Chemistry Letters
|
March 28, 2015
Pyrimidinone nicotinamide mimetics as selective tankyrase and wnt pathway inhibitors suitable for in vivo pharmacology
Jeffrey W Johannes, Lynsie Almeida, Bernard Barlaam, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 198) with videos related to
Sort By:
Page
of 20
Journal of Medicinal Chemistry
|
February 2, 2024
Identification of Novel, Selective Ataxia-Telangiectasia Mutated Kinase Inhibitors with the Ability to Penetrate the Blood-Brain Barrier: The Discovery of AZD1390
Kurt G Pike, Thomas A Hunt, Bernard Barlaam, et al.
Brain : a Journal of Neurology
|
June 18, 2010
Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency)
Philippa B Mills, Emma J Footitt, Kevin A Mills, et al.
Neurosurgery
|
March 8, 2024
40 Gray in 5 Fractions for Salvage Reirradiation of Spine Lesions Previously Treated With Stereotactic Body Radiotherapy
Assaf Moore, Zhigang Zhang, Teng Fei, et al.
Medchemcomm
|
October 18, 2016
Discovery of 4,6-disubstituted pyrimidines as potent inhibitors of the heat shock factor 1 (HSF1) stress pathway and CDK9
Carl S Rye, Nicola E A Chessum, Scott Lamont, et al.
Nature
|
August 10, 2017
An early modern human presence in Sumatra 73,000-63,000 years ago
K E Westaway, J Louys, R Due Awe, et al.
Nature Neuroscience
|
February 5, 2026
A generalizable foundation model for analysis of human brain MRI
Divyanshu Tak, Biniam A Garomsa, Anna Zapaishchykova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 24, 2024
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From <i>EGFR</i> and <i>ALK</i> Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC)
Luke R G Pike, Emily Miao, Lillian A Boe, et al.
Journal of Medicinal Chemistry
|
April 24, 2018
The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2 H-pyran-4-yl)-1,3-dihydro-2 H-imidazo[4,5- c]quinolin-2-one)
Kurt G Pike, Bernard Barlaam, Elaine Cadogan, et al.
Journal of Medicinal Chemistry
|
October 14, 2021
Discovery of a Series of 7-Azaindoles as Potent and Highly Selective CDK9 Inhibitors for Transient Target Engagement
Bernard Barlaam, Chris De Savi, Allan Dishington, et al.
ACS Medicinal Chemistry Letters
|
March 28, 2015
Pyrimidinone nicotinamide mimetics as selective tankyrase and wnt pathway inhibitors suitable for in vivo pharmacology
Jeffrey W Johannes, Lynsie Almeida, Bernard Barlaam, et al.
Page
of 20